Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis more and more likely to create a spin-off of Alcon worth $25bn to $35bn
Novartis more and more likely to create a spin-off of Alcon worth $25bn to $35bn
Novartis more and more likely to create a spin-off of Alcon worth $25bn to $35bn
Submitted by
admin
on October 26, 2017 - 10:51am
Source:
GoinPharma
News Tags:
Novartis
Alcon
spinoffs
Headline:
Novartis more and more likely to create a spin-off of Alcon worth $25bn to $35bn
Do Not Allow Advertisers to Use My Personal information
